Authors

  • Nishonov D.A., Tursunxodjaeva F.M., Sultanov O.A., Maxanov R.V., Yuldashev I.B., Berdiqulov N.S.

Keywords:

холестерин, витамин D2, витамин D3, атероматоз пилакчалар, мия инсулти, миокард инфаркт, аорта, фибролипоматоз, фиброматоз, атерокальциноз.

References

1. Anichkov, N.N. (2001). The combined theory of atherosclerosis pathogenesis and the role of lipid metabolism. Pathology International, 51(8), 591-597.

2. Brandenburg, V.M., Kramann, R., Koos, R. et al. (2010). Vitamin D – binding protein and arterial calcification in CKD: a prospective cohort study. J. Bone Miner. Res., 25(4), 921-932.

3. Brown, M.S., & Goldstein, J.L. (1986). A receptor-mediated pathway for cholesterol homeostasis. Science, 232(4746), 34-47.

4. Burlutskaya, A.V., & Tril, V.E. (2021). Epidemiological, clinical and morphological studies on early atherogenesis in fetuses and infants. Journal of Russian Cardiology, 26(S1), 42-48.

5. Chaulin, A.M., et al. (2020). Experimental models of atherosclerosis in rabbits: high-cholesterol diet protocols and genetic modifications. Cardiology Journal, 27(6), 765-772.

6. Davies, P. F. (2009). Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nature Clinical Practice Cardiovascular Medicine, 6(1), 16-26.

7. Demer, L.L., & Tintut, Y. (2008). Vascular calcification: pathobiology of a multifaceted disease. Circulation, 117(22), 2938-2948.

8. Gushchin, A.Ya., et al. (2017). Experimental approaches to evaluating atherosclerotic lesions and atherosclerosis progression in animal models. Biomedical Research, 28(14), 4412-4418.

9. Holick, M.F. (2007). Vitamin D deficiency. New Engl. J. Med., 357(3), 266-281.

10. Libby, P., Ridker, P.M., & Hansson, G.K. (2009). Inflammation in atherosclerosis: from pathophysiology to practice. J. Amer. Coll. Cardiol., 54(23), 2129-2138.

11. Lusis, A.J. (2000). Atherosclerosis. Nature, 407(6801), 233-241.

12. Ross, R. (1999). Atherosclerosis – an inflammatory disease. New Engl. J. Med., 340(2), 115-126.

13. Shanahan, C.M., Cary, N.R., Metcalfe, J.C., & Weissberg, P.L. (1999). High expression of genes for calcification-regulating proteins in human atherosclerotic plaques: evidence for skeletal regulation in vascular tissue. Circulation, 100(21), 2168-2176.

14. Shatnenabe, Y., et al. (1990). Genetic hyperlipidemic rabbit model and atherosclerosis progression. Atherosclerosis, 84(1), 85-93.

15. Stary, H.C., Chandler, A.B., Dinsmore, R.E. et al. (1995). A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. Circulation, 92(5), 1355-1374.

16. Tall, A.R., & Yvan-Charvet, L. (2015). Cholesterol, inflammation and innate immunity. Nat. Rev. Immunol., 15(2), 104-116.

17. Towler, D.A. (2008). Molecular and cellular regulators of vascular calcification. Prog. Cardiovasc. Dis., 50(4), 265-273.

18. Virmani, R., Kolodgie, F.D., Burke, A.P. et al. (2005). Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a progression marker. Circulation, 111(13), 1558-1566.

19. Watanabe, Y. (1980). Development of heritable hyperlipidemic rabbit strain (WHHL). Arteriosclerosis, 1(4).

20. Watanabe, Y. (1980). Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis, 36(2), 261-268.

21. Yang, F., Liu, L., & Li, M. (2013). Atherosclerotic disease in extracranial and intracranial carotid arteries and its role in ischemic cerebrovascular events. Journal of Stroke and Cerebrovascular Diseases, 22(8), 1234-1240.

22. Zhang, Q., Shang, A., & Zhang, S. (2017). Multifocal atherosclerotic disease prevalence in stroke patients. Neurology Research International, 2017, 8934521.